6
Views
0
CrossRef citations to date
0
Altmetric
Case Reports

Rapid Correction of Severe Hyperglycaemia During Hyperthermic Intraperitoneal Chemoperfusion With Oxaliplatin

, , &
Pages 256-259 | Published online: 11 Mar 2016

References

  • Elias D., Benizri E., Di Pietrantonio D., Menegon P., Malka D., Raynard B. Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis. Ann Surg Oncol, 2007, 14: 509–14.
  • Ceelen WP., Peeters M., Houtmeyers P., Breusegem C., De SomerF., Pattyn P. Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis. Ann Surg Oncol, 2008, 15: 53541.
  • Stephens A. D., Alderman R., Chang D. et al. Morbidity and mortality analysis of, 200 treatments with cytoreductive surgery and hyperthermic intra-operative intraperitoneal chemotherapy using the Coliseum technique. Ann Surg Oncol, 1999, 6: 790–6.
  • Lecomte P., Foubert L., Nobels F. et al. Dynamic tight glycaemic control during and after cardiac surgery is effective, feasible and safe. Anesth Analg, 2008, 107: 51–8.
  • Van den Berghe G., Wouters P., Weekers F. et al. Intensive insulin therapy in critically ill patients. N Engl J Med, 2001, 345: 1359–67.
  • D’Alessandro C., Leprince P., Golmard J. L. et al. Strict glycaemic control reduces EuroSCORE expected mortality in diabetic patients undergoing myocardial revascularization. J Thorac Cardiovasc Surg, 2007, 134: 29–37.
  • Van den Berghe G. Does tight blood glucose control during cardiac surgery improve patient outcome ? Ann Intern Med, 2007, 146: 307–8.
  • Ouattara A., Lecomte P., Le Manach Y. et al. Poor intra-operative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anaesthesiology, 2005, 103: 687–94.
  • Gandhi G. Y., Nuttall G. A., Abel M. D. et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomised trial. Ann Intern Med, 2007, 146: 233–43.
  • Bode B. W., Braithwaite S. S., Steed R. D., Davidson P. C. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract, 2004, 10 Suppl 2: 71–80.
  • Cammu G., Vermeiren K., Lecompte P., De Gendt S., Deloof T., Foubert L. Perioperative insulin management in patients undergoing tumor hepatectomy. J Clin Anesth, in press.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.